Article
A compounding pharmacy at the center of a national outbreak of fungal meningitis has voluntarily recalled all of its products, including numerous drugs for treating skin conditions.
Trauma-Induced Melanocyte Implantation Leading to Subcutaneous Melanoma
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Expert Insights on Personalizing Atopic Dermatitis Treatment
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Journal Digest: February 12
Daily Derm Times: February 11, 2025